Bernd-Rudiger Balda

Suggest Changes
Learn More
PURPOSE Low-dose interferon alfa (IFNalpha) has been shown to have limited effects in the adjuvant treatment of patients with intermediate- and high-risk primary melanoma. We hypothesized that a(More)
  • 1